GLIPIZIDE AND METFORMIN HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Glipizide And Metformin Hydrochloride, and what generic alternatives are available?
Glipizide And Metformin Hydrochloride is a drug marketed by Dash Pharms, Epic Pharma Llc, Heritage, Sun Pharm Inds Inc, Teva Pharms, and Zydus Pharms Usa Inc. and is included in six NDAs.
The generic ingredient in GLIPIZIDE AND METFORMIN HYDROCHLORIDE is glipizide; metformin hydrochloride. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the glipizide; metformin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Glipizide And Metformin Hydrochloride
A generic version of GLIPIZIDE AND METFORMIN HYDROCHLORIDE was approved as glipizide; metformin hydrochloride by EPIC PHARMA LLC on October 27th, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GLIPIZIDE AND METFORMIN HYDROCHLORIDE?
- What are the global sales for GLIPIZIDE AND METFORMIN HYDROCHLORIDE?
- What is Average Wholesale Price for GLIPIZIDE AND METFORMIN HYDROCHLORIDE?
Summary for GLIPIZIDE AND METFORMIN HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| Clinical Trials: | 11 |
| Patent Applications: | 10 |
| DailyMed Link: | GLIPIZIDE AND METFORMIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for GLIPIZIDE AND METFORMIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Merck Sharp & Dohme Corp. | Phase 4 |
| The Catholic University of Korea | Phase 4 |
| John H. Stroger Hospital | Phase 4 |
See all GLIPIZIDE AND METFORMIN HYDROCHLORIDE clinical trials
Pharmacology for GLIPIZIDE AND METFORMIN HYDROCHLORIDE
| Drug Class | Biguanide Sulfonylurea |
US Patents and Regulatory Information for GLIPIZIDE AND METFORMIN HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dash Pharms | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | glipizide; metformin hydrochloride | TABLET;ORAL | 078083-001 | Apr 12, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Pharms Usa Inc | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | glipizide; metformin hydrochloride | TABLET;ORAL | 078905-003 | Jan 31, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Heritage | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | glipizide; metformin hydrochloride | TABLET;ORAL | 078728-001 | Jun 23, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
